The UK-Rapid Test Consortium (UK-RTC), a group of scientists and expert medical manufacturers led by Abingdon Health, has announced that its point-of-care and home Covid-19 antibody test meets regulatory guidelines.
The UK-RTC was set up in April 2020 to develop and manufacture millions of Covid-19 antibody tests to determine if someone’s immune system has responded to infection from the virus. This milestone is significant because it means the technical design and manufacturing specifications for the antibody testing kit are complete and so preparation for mass…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
